Literature DB >> 15912255

Malignant transformation of pleomorphic xanthoastrocytoma.

T Nakajima1, T Kumabe, H Shamoto, M Watanabe, H Suzuki, T Tominaga.   

Abstract

A 31-year-old woman presented with a pleomorphic xantho-astrocytoma (PXA) manifesting as epilepsy. The tumour was partially resected. Histological examination revealed cellular pleomorphism and cytoplasmic vacuolation consistent with PXA, but no mitoses, necrosis, or endothelial proliferation. Follow-up neuro-imaging showed the residual tumour had grown rapidly with dissemination in the spinal cord. The recurrent lesion was totally resected and was shown to be glioblastoma. The patient has survived without signs of recurrence for 36 months after adjuvant radiochemotherapy. The biological behaviour of PXA cannot be predicted based on the histological features and careful follow up is essential.

Entities:  

Mesh:

Year:  2005        PMID: 15912255     DOI: 10.1007/s00701-005-0549-8

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  16 in total

1.  Pleomorphic xanthoastrocytoma with malignant transformation and multiple recurrences in an Iranian girl.

Authors:  Fariba Binesh; Ali Akhavan; Hossein Navabii
Journal:  BMJ Case Rep       Date:  2012-03-20

Review 2.  MR and CT imaging of 24 pleomorphic xanthoastrocytomas (PXA) and a review of the literature.

Authors:  Ana M Crespo-Rodríguez; James G Smirniotopoulos; Elisabeth J Rushing
Journal:  Neuroradiology       Date:  2007-01-05       Impact factor: 2.804

Review 3.  Epilepsy associated tumors: Review article.

Authors:  Marco Giulioni; Gianluca Marucci; Matteo Martinoni; Anna Federica Marliani; Francesco Toni; Fiorina Bartiromo; Lilia Volpi; Patrizia Riguzzi; Francesca Bisulli; Ilaria Naldi; Roberto Michelucci; Agostino Baruzzi; Paolo Tinuper; Guido Rubboli
Journal:  World J Clin Cases       Date:  2014-11-16       Impact factor: 1.337

4.  Prognostic factors and therapeutic outcomes in 22 patients with pleomorphic xanthoastrocytoma.

Authors:  Sungryong Lim; Jeong Hoon Kim; Sun A Kim; Eun Suk Park; Young Shin Ra; Chang Jin Kim
Journal:  J Korean Neurosurg Soc       Date:  2013-05-31

5.  Patterns of care and outcomes of patients with pleomorphic xanthoastrocytoma: a SEER analysis.

Authors:  Stephanie M Perkins; Nandita Mitra; Wan Fei; Eric T Shinohara
Journal:  J Neurooncol       Date:  2012-07-28       Impact factor: 4.130

Review 6.  Aggressive behavior and anaplasia in pleomorphic xanthoastrocytoma: a plea for a revision of the current WHO classification.

Authors:  Nesibe Kahramancetin; Tarik Tihan
Journal:  CNS Oncol       Date:  2013-11

Review 7.  Primary anaplastic pleomorphic xanthoastrocytoma with widespread neuroaxis dissemination at diagnosis--a pediatric case report and review of the literature.

Authors:  Toshiyuki Okazaki; Teruyoshi Kageji; Kazuhito Matsuzaki; Hidehisa Horiguchi; Takanori Hirose; Hiroyoshi Watanabe; Toshihiro Ohnishi; Shinji Nagahiro
Journal:  J Neurooncol       Date:  2009-03-27       Impact factor: 4.130

8.  A rare clinical presentation: a pleomorphic xanthoastrocytoma presenting with intracerebral haemorrhage and metastasizing vigorously-case report and review of the literature.

Authors:  Gülden Demirci Otluoğlu; M Memet Özek
Journal:  Childs Nerv Syst       Date:  2018-09-04       Impact factor: 1.475

9.  Long-term control of disseminated pleomorphic xanthoastrocytoma with anaplastic features by means of stereotactic irradiation.

Authors:  Tomoyuki Koga; Akio Morita; Keisuke Maruyama; Minoru Tanaka; Yasushi Ino; Junji Shibahara; David N Louis; Guido Reifenberger; Jun Itami; Ryusuke Hara; Nobuhito Saito; Tomoki Todo
Journal:  Neuro Oncol       Date:  2009-01-22       Impact factor: 12.300

Review 10.  Rare primary central nervous system tumors.

Authors:  Charlotte Dai Kubicky; Arjun Sahgal; Eric L Chang; Simon S Lo
Journal:  Rare Tumors       Date:  2014-08-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.